The role of anti-phospholipid antibodies in autoimmune reproductive failure

Reproduction

Volumn 151, Issue 5, 2016, Pages R79-R90

  Pantham, Priyadarshini ^a   Abrahams, Vikki M ^b   Chamley, Lawrence W ^c  

^a University of Colorado Denver and Children s Hospital Colorado   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

BETA2 GLYCOPROTEIN 1 ANTIBODY; CYTOKINE; HEPARIN; HORMONE; PHOSPHOLIPID ANTIBODY; AUTOANTIBODY;

ANTIPHOSPHOLIPID SYNDROME; AUTOIMMUNE DISEASE; AUTOIMMUNE REPRODUCTIVE FAILURE; CELL DEATH; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CYTOKINE PRODUCTION; GENITAL SYSTEM DISEASE; HORMONE SYNTHESIS; HUMAN; IN VITRO STUDY; INFERTILITY; NONHUMAN; PLACENTA; PREGNANCY COMPLICATION; PRIORITY JOURNAL; REVIEW; TROPHOBLAST; ANIMAL; COMPLICATION; FEMALE; IMMUNOLOGY; INFERTILITY, FEMALE; PREGNANCY; REPRODUCTION;

ANIMALS; ANTIBODIES, ANTIPHOSPHOLIPID; AUTOANTIBODIES; AUTOIMMUNE DISEASES; FEMALE; HUMANS; INFERTILITY, FEMALE; PREGNANCY; REPRODUCTION;

EID: 84968773485     PISSN: 14701626     EISSN: 17417899     Source Type: Journal    
DOI: 10.1530/REP-15-0545     Document Type: Review

References (115)

1. Abrahams VM 2009 Mechanisms of antiphospholipid antibody-associated pregnancy complications. Thrombosis Research 124 521-525. (doi:10.1016/j.thromres.2009.07.011)
2. Albert CR, Schlesinger WJ, Viall CA, Mulla MJ, Brosens JJ, Chamley LW & Abrahams VM 2014 Effect of hydroxychloroquine on antiphospholipid antibody-induced changes in first trimester trophoblast function. American Journal of Reproductive Immunology 71 154-164. (doi:10.1111/aji.2014.71.issue-2)
3. Alvarez AM, Mulla MJ, Chamley LW, Cadavid AP & Abrahams VM 2015 Aspirin-triggered lipoxin prevents antiphospholipid antibody effects on human trophoblast migration and endothelial cell interactions. Arthritis & Rheumatology 67 488-497. (doi:10.1002/art.v67.2)
4. Andreoli L, Chighizola CB, Nalli C, Gerosa M, Borghi MO, Pregnolato F, Grossi C, Zanola A, Allegri F, Norman GL et al. 2015 Clinical characterization of antiphospholipid syndrome by detection of IgG antibodies against β2-glycoprotein i domain 1 and domain 4/5: ratio of anti-domain 1 to anti-domain 4/5 as a useful new biomarker for antiphospholipid syndrome. Arthritis & Rheumatology 67 2196-2204. (doi:10.1002/art.39187)
5. Asherson R & Cervera R 1993 Anticardiolipin antibodies, chronic biologic false-positive tests for syphilis and other antiphospholipid antibodies. In Duboi's Systemic Lupus Erythematosus, pp 233-245. Eds DJ Wallace & BH Hahn. Philadelphia, PA, USA: Lea & Febiger.
6. Askelund K & Chamley L 2011 Trophoblast deportation part I: review of the evidence demonstrating trophoblast shedding and deportation during human pregnancy. Placenta 32 716-723. (doi:10.1097/MD.0000000000002382)
7. Atsumi T, Ieko M, Bertolaccini ML, Ichikawa K, Tsutsumi A, Matsuura E & Koike T 2000 Association of autoantibodies against the phosphatidylserine-prothrombin complex with manifestations of the antiphospholipid syndrome and with the presence of lupus anticoagulant. Arthritis & Rheumatology 43 1982-1993. (doi:10.1002/1529-0131(200009)43:9<1982::AID-ANR9>3.0.CO;2-2)
8. Bakimer R, Fishman P, Blank M, Sredni B, Djaldetti M & Shoenfeld Y 1992 Induction of primary antiphospholipid syndrome in mice by immunization with a human monoclonal anticardiolipin antibody (H-3). Journal of Clinical Investigation 89 1558-1563. (doi:10.1172/JCI115749)
9. Bertolaccini ML, Amengual O, Atsumi T, Binder WL, de Laat B, Forastiero R, Kutteh WH, Lambert M, Matsubayashi H, Murthy V et al. 2011 'Non-criteria' aPL tests: report of a task force and preconference workshop at the 13th International Congress on Antiphospholipid Antibodies, Galveston, TX, USA, April 2010. Lupus 20 191-205. (doi:10.1177/0961203310397082)
10. Blank M & Shoenfeld Y 2004 Beta-2-glycoprotein-I, infections, antiphospholipid syndrome and therapeutic considerations. Clinical Immunology 112 190-199. (doi:10.1016/j.clim.2004.02.018)
11. Blank M, Cohen J, Toder V & Shoenfeld Y 1991 Induction of antiphospholipid syndrome in naive mice with mouse lupus monoclonal and human polyclonal anti-cardiolipin antibodies. PNAS 88 3069-3073. (doi:10.1073/pnas.88.8.3069)
12. Blank M, Faden D, Tincani A, Kopolovic J, Goldberg I, Gilburd B, Allegri F, Balestrieri G, Valesini G & Shoenfeld Y 1994 Immunization with anticardiolipin cofactor (β-2-glycoprotein I) induces experimental antiphospholipid syndrome in naive mice. Journal of Autoimmunity 7 441-455. (doi:10.1006/jaut.1994.1032)
13. Bose P, Black S, Kadyrov M, Bartz C, Shlebak A, Regan L & Huppertz B 2004 Adverse effects of lupus anticoagulant positive blood sera on placental viability can be prevented by heparin in vitro. American Journal of Obstetrics and Gynecology 191 2125-2131. (doi:10.1016/j. ajog.2004.05.014)
14. Bramham K, Thomas M, Nelson-Piercy C, Khamashta M & Hunt BJ 2011 First-trimester low-dose prednisolone in refractory antiphospholipid antibody-related pregnancy loss. Blood 117 6948-6951. (doi:10.1182/blood-2011-02-339234)
15. Branch DW, Andres R, Digre KB, Rote NS & Scott JR 1989 The association of antiphospholipid antibodies with severe preeclampsia. Obstetrics and Gynecology 73 541-545.
16. Branch DW, Dudley DJ, Mitchell MD, Creighton KA, Abbott TM, Hammond EH & Daynes RA 1990 Immunoglobulin G fractions from patients with antiphospholipid antibodies cause fetal death in BALB/c mice: a model for autoimmune fetal loss. American Journal of Obstetrics and Gynecology 163 210-216. (doi:10.1016/S0002-9378(11)90700-5)
17. Brownfoot FC, Tong S, Hannan NJ, Binder NK, Walker SP, Cannon P, Hastie R, Onda K & Kaitu'u-Lino TJ 2015 Effects of pravastatin on human placenta, endothelium, and women with severe preeclampsia. Hypertension 66 687-697 (discussion 445). (doi:10.1161/HYPERTENSIONAHA.115.05445)
18. Buckingham KL & Chamley LW 2009 A critical assessment of the role of antiphospholipid antibodies in infertility. Journal of Reproductive Immunology 80 132-145. (doi:10.1093/humrep/deq100)
19. Carroll TY, Mulla MJ, Han CS, Brosens JJ, Chamley LW, Giles I, Pericleous C, Rahman A, Sfakianaki AK, Paidas MJ et al. 2011 Modulation of trophoblast angiogenic factor secretion by antiphospholipid antibodies is not reversed by heparin. American Journal of Reproductive Immunology 66 286-296. (doi:10.1111/aji.2011.66.issue-4)
20. Cervera R, Serrano R, Pons-Estel GJ, Ceberio-Hualde L, Shoenfeld Y, de Ramon E, Buonaiuto V, Jacobsen S, Zeher MM, Tarr T et al. 2015 Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients. Annals of the Rheumatic Diseases 74 1011-1018. (doi:10.1136/annrheumdis-2013-204838)
21. Chamley LW 1997 Antiphospholipid antibodies or not? The role of β2 glycoprotein 1 in autoantibody-mediated pregnancy loss. Journal of Reproductive Immunology 36 123. (doi:10.1016/S0165-0378(97)00063-6)
22. Chamley LW, Pattison NS & McKay EJ 1993 Elution of anticardiolipin antibodies and their cofactor β2-glycoprotein 1 from the placentae of patients with a poor obstetric history. Journal of Reproductive Immunology 25 209-220. (doi:10.1067/mob.2000.106754)
23. Chamley LW, Konarkowska B, Duncalf AM, Mitchell MD & Johnson PM 2001 Is interleukin-3 important in antiphospholipid antibody-mediated pregnancy failure? Fertility and Sterility 76 700-706. (doi:10.1016/S0015-0282(01)01984-7)
24. Chen Q, Viall C, Kang Y, Liu B, Stone P & Chamley L 2009 Antiphospholipid antibodies increase non-apoptotic trophoblast shedding: a contribution to the pathogenesis of pre-eclampsia in affected women? Placenta 30 767-773. (doi:10.1016/j.placenta.2009.06.008)
25. Chen Q, Guo F, Jin HY, Lau S, Stone P & Chamley L 2012 Phagocytosis of apoptotic trophoblastic debris protects endothelial cells against activation. Placenta 33 548-553. (doi:10.1016/j.placenta.2012.03.007)
26. Ding X, Yang Z, Han Y & Yu H 2014 Long-chain fatty acid oxidation changes in a β2 glycoprotein I-induced preeclampsia-like mouse model. Placenta 35 392-397. (doi:10.1016/j.placenta.2014.03.013)
27. Di Simone N, Ferrazzani S, Castellani R, De Carolis S, Mancuso S & Caruso A 1997 Heparin and low-dose aspirin restore placental human chorionic gonadotrophin secretion abolished by antiphospholipid antibody-containing sera. Human Reproduction 12 2061-2065. (doi:10.1093/humrep/12.9.2061)
28. Di Simone N, Caliandro D, Castellani R, Ferrazzani S & Caruso A 2000a Interleukin-3 and human trophoblast: in vitro explanations for the effect of interleukin in patients with antiphospholipid antibody syndrome. Fertility and Sterility 73 1194-1200. (doi:10.1016/S0015-0282(00)00533-1)
29. Di Simone N, Meroni PL, de Papa N, Raschi E, Caliandro D, De Carolis CS, Khamashta MA, Atsumi T, Hughes GR & Balestrieri G 2000b Antiphospholipid antibodies affect trophoblast gonadotropin secretion and invasiveness by binding directly and through adhered β2-glycoprotein I. Arthritis & Rheumatology 43 140. (doi:10.1002/(ISSN)1529-0131)
30. Di Simone N, Castellani R, Caliandro D & Caruso A 2001 Monoclonal anti-annexin V antibody inhibits trophoblast gonadotropin secretion and induces syncytiotrophoblast apoptosis. Biology of Reproduction 65 1766. (doi:10.1016/S0303-7207(01)00648-7)
31. Di Simone N, Castellani R, Caliandro D & Caruso A 2002 Antiphospholid antibodies regulate the expression of trophoblast cell adhesion molecules. Fertility and Sterility 77 805. (doi:10.1016/S0303-7207(01)00648-7)
32. Di Simone N, Castellani R, Raschi E, Borghi MO, Meroni PL & Caruso A 2006 Anti-β-2 glycoprotein I antibodies affect Bcl-2 and Bax trophoblast expression without evidence of apoptosis. Annals of the New York Academy of Sciences 1069 364-376. (doi:10.1002/art.27361)
33. Di Simone N, Marana R, Castellani R, Di Nicuolo F, D'Alessio MC, Raschi E, Borghi MO, Chen PP, Sanguinetti M, Caruso A et al. 2010 Decreased expression of heparin-binding epidermal growth factor-like growth factor as a newly identified pathogenic mechanism of antiphospholipidmediated defective placentation. Arthritis & Rheumatology 62 1504-1512. (doi:10.1002/art.27361)
34. Drakeley AJ, Quenby S & Farquharson RG 1998 Mid-trimester loss-appraisal of a screening protocol. Human Reproduction 13 1975-1980. (doi:10.1093/humrep/13.7.1975)
35. Duckitt K & Harrington D 2005 Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies. BMJ 330 565-567. (doi:10.1136/bmj.38380.674340.E0)
36. Faden D, Tincani A, Tanzi P, Spatola L, Lojacono A, Tarantini M & Balestrieri G 1997 Anti-β2 glycoprotein I antibodies in a general obstetric population: preliminary results on the prevalence and correlation with pregnancy outcome. Anti-β2 glycoprotein I antibodies are associated with some obstetrical complications, mainly preeclampsia-eclampsia. European Journal of Obstetrics, Gynecology, and Reproductive Biology 73 37 (doi:10.1016/S0301-2115(97)02736-X)
37. Farquharson RG, Quenby S & Greaves M 2002 Antiphospholipid syndrome in pregnancy: a randomized, controlled trial of treatment. Obstetrics and Gynecology 100 408-413. (doi:10.1056/NEJMoa1504927)
38. Forastiero R, Papalardo E, Watkins M, Nguyen H, Quirbach C, Jaskal K, Kast M, Teodorescu M, Lakos G, Binder W et al. 2014 Evaluation of different immunoassays for the detection of antiphospholipid antibodies: report of a wet workshop during the 13th International Congress on Antiphospholipid Antibodies. Clinica Chimica Acta 428 99-105. (doi:10.1016/j.cca.2013.11.009)
39. Fournier T, Guibourdenche J & Evain-Brion D 2015 Review: hCGs: different sources of production, different glycoforms and functions. Placenta 36 (Suppl 1) S60-S65. (doi:10.1016/j.placenta.2015.02.002)
40. Galarza-Maldonado C, Kourilovitch MR, Perez-Fernandez OM, Gaybor M, Cordero C, Cabrera S & Soroka NF 2012 Obstetric antiphospholipid syndrome. Autoimmunity Reviews 11 288-295. (doi:10.1016/j. autrev.2011.10.006)
41. Galli M 2012 Interpretation and recommended testing for antiphospholipid antibodies. Seminars in Thrombosis and Hemostasis 38 348-352. (doi: 10.1055/s-0032-1304716)
42. Gharavi AE, Harris EN, Asherson RA & Hughes GR 1987 Anticardiolipin antibodies: isotype distribution and phospholipid specificity. Annals of the Rheumatic Diseases 46 1-6. (doi:10.1136/ard.46.8.605)
43. Gharavi AE, Mellors RC & Elkon KB 1989 IgG anti-cardiolipin antibodies in murine lupus. Clinical and Experimental Immunology 78 233-238.
44. Ginsberg JS, Wells PS, Brill-Edwards P, Donovan D, Moffatt K, Johnston M, Stevens P & Hirsh J 1995 Antiphospholipid antibodies and venous thromboembolism. Blood 86 3685-3691.
45. Girardi G, Berman J, Redecha P, Spruce L, Thurman JM, Kraus D, Hollmann TJ, Casali P, Caroll MC, Wetsel RA et al. 2003 Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome. Journal of Clinical Investigation 112 1644-1654. (doi:10.1172/JCI200318817)
46. Girardi G, Redecha P & Salmon JE 2004 Heparin prevents antiphospholipid antibody-induced fetal loss by inhibiting complement activation. Nature Medicine 10 1222-1226. (doi:10.1182/blood-2009-01-199117)
47. Gysler SM, Mulla MJ, Stuhlman M, Sfakianaki AK, Paidas MJ, Stanwood NL, Gariepy A, Brosens JJ, Chamley LW & Abrahams VM 2015 Vitamin D reverses aPL-induced inflammation and LMWH-induced sFlt-1 release by human trophoblast. American Journal of Reproductive Immunology 73 242-250. (doi:10.1111/aji.2015.73.issue-3)
48. Haeger M, Unander M, Norder-Hansson B, Tylman M & Bengtsson A 1992 Complement, neutrophil, and macrophage activation in women with severe preeclampsia and the syndrome of hemolysis, elevated liver enzymes, and low platelet count. Obstetrics and Gynecology 79 19-26.
49. Hirakawa E, Saito K, Hirata S, Atsumi T, Koike T & Tanaka Y 2012 A case of catastrophic antiphospholipid antibody syndrome complicated with systemic lupus erythematosus, double positive for anti-cardiolipin/β(2) glycoprotein I and anti-phosphatidylserine/prothrombin autoantibodies. Modern Rheumatology 22 769-773. (doi:10.3109/s10165-011-0563-z)
50. Holers VM, Girardi G, Mo L, Guthridge JM, Molina H, Pierangeli SS, Espinola R, Xiaowei LE, Mao D, Vialpando CG et al. 2002 Complement C3 activation is required for antiphospholipid antibody-induced fetal loss. Journal of Experimental Medicine 195 211-220. (doi:10.1084/jem.200116116)
51. Horkko S, Miller E, Dudl E, Reaven P, Curtiss LK, Zvaifler NJ, Terkeltaub R, Pierangeli SS, Branch DW, Palinski W et al. 1996 Antiphospholipid antibodies are directed against epitopes of oxidized phospholipids. Recognition of cardiolipin by monoclonal antibodies to epitopes of oxidized low density lipoprotein. Journal of Clinical Investigation 98 815-825. (doi:10.1172/JCI118854)
52. Ichikawa G, Yamamoto T, Chishima F, Nakamura A, Kuno S, Murase T & Suzuki M 2011 Effects of anti-β2-glycoprotein I antibody on PlGF, VEGF and sVEGFR1 production from cultured choriocarcinoma cell line. Journal of Obstetrics and Gynaecology Research 37 1076-1083. (doi:10.1111/jog.2011.37.issue-8)
53. Iverson GM, Victoria EJ & Marquis DM 1998 Anti-β2 glycoprotein I (β2GPI) autoantibodies recognize an epitope on the first domain of β2GPI. PNAS 95 15542-15546. (doi:10.1016/j.cccn.2004.01.008)
54. Iwasawa Y, Kawana K, Fujii T, Schust DJ, Nagamatsu T, Kawana Y, Sayama S, Miura S, Matsumoto J, Adachi K et al. 2012 A possible coagulation-independent mechanism for pregnancy loss involving β(2) glycoprotein 1-dependent antiphospholipid antibodies and CD1d. American Journal of Reproductive Immunology 67 54-65. (doi:10.1111/aji.2011.67.issue-1)
55. de Jesus GR, Agmon-Levin N, Andrade CA, Andreoli L, Chighizola CB, Porter TF, Salmon J, Silver RM, Tincani A & Branch DW 2014 14th International Congress on Antiphospholipid Antibodies Task Force report on obstetric antiphospholipid syndrome. Autoimmunity Reviews 13 795-813. (doi:10.1016/j.autrev.2014.02.003)
56. Katano K, Aoki A, Sasa H, Ogasawara M, Matsuura E & Yagami Y 1996 beta 2-Glycoprotein I-dependent anticardiolipin antibodies as a predictor of adverse pregnancy outcomes in healthy pregnant women. Human Reproduction 11 509-512. (doi:10.1093/HUMREP/11.3.509)
57. Katsuragawa H, Kanzaki H, Inoue T, Hirano T, Mori T & Rote NS 1997 Monoclonal antibody against phosphatidylserine inhibits in vitro human trophoblastic hormone production and invasion. Biology of Reproduction 56 50-58. (doi:10.1095/biolreprod56.1.50)
58. Krikun G, Lockwood C, Wu X, Zhou X, Guller S, Calandri C, Guha A, Nemerson Y & Rand J 1994 The expression of the placental anticoagulant protein, annexin V, by villous trophoblasts: immunolocalization and in vitro regulation. Placenta 15 601. (doi:10.1016/S0143-4004(05)80407-2)
59. Lakasing L, Campa J, Poston R, Khamashta M & Poston L 1999 Normal expression of tissue factor, thrombomodulin, and annexin V in placentas from women with antiphospholipid syndrome. American Journal of Obstetrics and Gynecology 181 180. (doi:10.1016/S0002-9378(99)70457-6)
60. de Laat HB, Derksen RH, Urbanus RT, Roest M & de Groot PG 2004 beta 2-Glycoprotein I-dependent lupus anticoagulant highly correlates with thrombosis in the antiphospholipid syndrome. Blood 104 3598-3602. (doi:10.1182/blood-2004-03-1107)
61. de Laat B, Wu X, van Lummel M, Derksen R, de Groot P & Rand J 2007 Correlation between antiphospholipid antibodies that recognize domain I of β2-glycoprotein I and a reduction in the anticoagulant activity of annexin A5. Blood 109 1490. (doi:10.1182/blood-2006-07-030148)
62. de Laat B, Pengo V, Pabinger I, Musial J, Voskuyl A, Bultink I, Ruffatti A, Rozman B, Kveder T & de Moerloose P 2009 The association between circulating antibodies against domain I of β2-glycoprotein I and thrombosis: an International Multicenter Study. Journal of Thrombosis and Haemostasis 7 1767. (doi:10.1111/jth.2009.7.issue-11)
63. Lefkou E, Mamopoulos A, Fragakis N, Dagklis T, Vosnakis C, Nounopoulos E, Rousso D & Girardi G 2014 Clinical improvement and successful pregnancy in a preeclamptic patient with antiphospholipid syndrome treated with pravastatin. Hypertension 63 e118-e119. (doi:10.1161/HYPERTENSIONAHA.114.03115)
64. Love PE & Santoro SA 1990 Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Prevalence and clinical significance. Annals of Internal Medicine 112 682-698. (doi:10.1073/pnas.1520245113)
65. Marchetti T, Ruffatti A, Wuillemin C, de Moerloose P & Cohen M 2014 Hydroxychloroquine restores trophoblast fusion affected by antiphospholipid antibodies. Journal of Thrombosis and Haemostasis 12 910-920. (doi:10.1111/jth.2014.12.issue-6)
66. Mayhew TM 2008 Taking tissue samples from the placenta: an illustration of principles and strategies. Placenta 29 1-14. (doi:10.1016/j.placenta.2007.05.010)
67. Maynard SE, Min JY, Merchan J, Lim KH, Li J, Mondal S, Libermann TA, Morgan JP, Sellke FW & Stillman IE 2003 Excess placental soluble fmslike tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. Journal of Clinical Investigation 111 649-658. (doi:10.1172/JCI17189)
68. McIntyre JA, Wagenknecht DR & Sugi T 1997 Phospholipid binding plasma proteins required for antiphospholipid antibody detection-an overview. American Journal of Reproductive Immunology 37 101-110. (doi:10.3109/08916934.2015.1008464)
69. Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, Derksen RH, de Groot PG, Koike T, Meroni PL et al. 2006 International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). Journal of Thrombosis and Haemostasis 4 295-306. (doi:10.1111/jth.2006.4.issue-2)
70. Mulla MJ, Brosens JJ, Chamley LW, Giles I, Pericleous C, Rahman A, Joyce SK, Panda B, Paidas MJ & Abrahams VM 2009 Antiphospholipid antibodies induce a pro-inflammatory response in first trimester trophoblast via the TLR4/MyD88 pathway. American Journal of Reproductive Immunology 62 96-111. (doi:10.1111/j.1600-0897.2009.00717.x)
71. Mulla MJ, Myrtolli K, Brosens JJ, Chamley LW, Kwak-Kim JY, Paidas MJ & Abrahams VM 2010 Antiphospholipid antibodies limit trophoblast migration by reducing IL-6 production and STAT3 activity. American Journal of Reproductive Immunology 63 339-348. (doi:10.1111/j.1600-0897.2009.00805.x)
72. Mulla MJ, Salmon JE, Chamley LW, Brosens JJ, Boeras CM, Kavathas PB & Abrahams VM 2013 A role for uric acid and the Nalp3 inflammasome in antiphospholipid antibody-induced IL-1β production by human first trimester trophoblast. PLoS ONE 8 e65237. (doi:10.1371/journal. pone.0065237)
73. Noble LS, Kutteh WH, Lashey N, Franklin RD & Herrada J 2005 Antiphospholipid antibodies associated with recurrent pregnancy loss: prospective, multicenter, controlled pilot study comparing treatment with low-molecular-weight heparin versus unfractionated heparin. Fertility and Sterility 83 684-690. (doi:10.1016/j.fertnstert.2004.11.002)
74. Odiari E, Mulla M, Sfakianaki A, Paidas M, Stanwood N, Gariepy A, Brosens J, Chamley L & Abrahams V 2012 Pravastatin does not prevent antiphospholipid antibody-mediated changes in human first trimester trophoblast function. Human Reproduction 27 2933-2940. (doi:10.1093/humrep/des288)
75. Oosting JD, Derksen RH, Bobbink IW, Hackeng TM, Bouma BN & de Groot PG 1993 Antiphospholipid antibodies directed against a combination of phospholipids with prothrombin, protein C, or protein S: an explanation for their pathogenic mechanism? Blood 81 2618-2625.
76. Ornoy A, Yacobi S, Matalon ST, Blank M, Blumenfeld Z, Miller RK & Shoenfeld Y 2003 The effects of antiphospholipid antibodies obtained from women with SLE/APS and associated pregnancy loss on rat embryos and placental explants in culture. Lupus 12 573-578. (doi:10.1191/096 1203303lu405oa)
77. Out HJ, Kooijman CD, Bruinse HW & Derksen RH 1991 Histopathological findings in placentae from patients with intra-uterine fetal death and anti-phospholipid antibodies. European Journal of Obstetrics, Gynecology, and Reproductive Biology 41 179-186. (doi:10.1016/0028-2243(91)90021-C)
78. Pangborn MC 1941 A new serologically active phospholipid from beef heart. Proceedings of the Society of Experimental Biology 48 484-486.
79. Pantham P, Rosario R, Chen Q & Chamley L 2012 Transcriptomic analysis of placenta affected by antiphospholipid antibodies: following the TRAIL of trophoblast death. Journal of Reproductive Immunology 94 151-154. (doi:10.1016/j.jri.2012.03.487)
80. Pantham P, Viall CA, Chen Q, Kleffmann T, Print CG & Chamley LW 2015a Antiphospholipid antibodies bind syncytiotrophoblast mitochondria and alter the proteome of extruded syncytial nuclear aggregates. Placenta 36 1463-1473. (doi:10.1016/j.placenta.2015.10.006)
81. Pantham P, Heazell AE, Mullard G, Begley P, Chen Q, Brown M, Dunn WB & Chamley LW 2015b Antiphospholipid antibodies alter cell-death-regulating lipid metabolites in first and third trimester human placentae. American Journal of Reproductive Immunology 74 181-199. (doi:10.1111/aji.12387)
82. Pijnenborg R, Vercruysse L & Hanssens M 2006 The uterine spiral arteries in human pregnancy: facts and controversies. Placenta 27 939-958. (doi:10.1016/j.placenta.2013.01.002)
83. Poulton K, Ripoll VM, Pericleous C, Meroni PL, Gerosa M, Ioannou Y, Rahman A & Giles IP 2015 Purified IgG from patients with obstetric but not IgG from non-obstetric antiphospholipid syndrome inhibit trophoblast invasion. American Journal of Reproductive Immunology 73 390-401. (doi:10.1111/aji.2015.73.issue-5)
84. Quenby S, Mountfield S, Cartwright JE, Whitley GS, Chamley L & Vince G 2005 Antiphospholipid antibodies prevent extravillous trophoblast differentiation. Fertility and Sterility 83 691-698. (doi:10.1016/j.fertnstert.2004.07.978)
85. Rai R & Regan L 2002 Antiphospholipid syndrome in pregnancy: a randomized, controlled trial of treatment. Obstetrics and Gynecology 100 1354.
86. Rand J & Wu X 1999 Antibody-mediated disruption of the annexin-V antithrombotic shield: a new mechanism for thrombosis in the antiphospholipid syndrome. Thrombosis and Haemostasis 82 649.
87. Rand J, Wu X, Guller S, Gil J, Guha A, Scher J & Lockwood C 1994 Reduction of annexin-V (placental anticoagulant protein-I) on placental villi of women with antiphospholipid antibodies and recurrent spontaneous abortion. American Journal of Obstetrics and Gynecology 171 1566. (doi:10.1016/0002-9378(94)90403-0)
88. Rand J, Wu X, Guller S, Scher J, Andree H & Lockwood C 1997 Antiphospholipid immunoglobulin G antibodies reduce annexin-V levels on syncytiotrophoblast apical membranes and in culture media of placental villi. American Journal of Obstetrics and Gynecology 177 918. (doi:10.1016/S0002-9378(97)70294-1)
89. Rand J, Wu X, Andree H, Ross J, Rusinova E, Gascon-Lema M, Calandri C & Harpel P 1998 Antiphospholipid antibodies accelerate plasma coagulation by inhibiting annexin-V binding to phospholipids: a "lupus procoagulant" phenomenon. Blood 92 1652.
90. Rand JH, Wu XX, Quinn AS, Chen PP, McCrae KR, Bovill EG & Taatjes DJ 2003 Human monoclonal antiphospholipid antibodies disrupt the annexin A5 anticoagulant crystal shield on phospholipid bilayers: evidence from atomic force microscopy and functional assay. American Journal of Pathology 163 1193. (doi:10.1016/S0002-9440(10)63479-7)
91. Rand J, Wu X, Lapinski R, van Heerde W, Reutelingsperger C, Chen P & Ortel T 2004 Detection of antibody-mediated reduction of annexin A5 anticoagulant activity in plasmas of patients with the antiphospholipid syndrome. Blood 104 2783. (doi:10.1182/blood-2004-01-0203)
92. Rand J, Arslan A, Wu X, Wein R, Mulholland J, Shah M, van Heerde W, Reutelingsperger C, Lockwood C & Kuczynski E 2006 Reduction of circulating annexin A5 levels and resistance to annexin A5 anticoagulant activity in women with recurrent spontaneous pregnancy losses. American Journal of Obstetrics and Gynecology 194 182. (doi:10.1016/j. ajog.2005.05.034)
93. Robertson SA, Roberts CT, van Beijering E, Pensa K, Sheng Y, Shi T & Krilis SA 2004 Effect of β2-glycoprotein I null mutation on reproductive outcome and antiphospholipid antibody-mediated pregnancy pathology in mice. Molecular Human Reproduction 10 409-416. (doi:10.1093/molehr/gah058)
94. Rodriguez-Garcia V, Ioannou Y, Fernandez-Nebro A, Isenberg DA & Giles IP 2015 Examining the prevalence of non-criteria anti-phospholipid antibodies in patients with anti-phospholipid syndrome: a systematic review. Rheumatology 54 2042-2050. (doi:10.1093/rheumatology/kev226)
95. Roggenbuck D, Egerer K, von Landenberg P, Hiemann R, Feist E, Burmester GR & Dorner T 2012 Antiphospholipid antibody profiling: time for a new technical approach? Autoimmunity Reviews 11 821-826. (doi:10.1016/j.autrev.2012.02.016)
96. Rosenberg VA, Buhimschi IA, Lockwood CJ, Paidas MJ, Dulay AT, Ramma W, Abdel-Razeq SS, Zhao G, Ahmad S, Ahmed A et al. 2011 Heparin elevates circulating soluble fms-like tyrosine kinase-1 immunoreactivity in pregnant women receiving anticoagulation therapy. Circulation 124 2543-2553. (doi:10.1161/CIRCULATIONAHA.111.046821)
97. Rote NS, Dostal-Johnson D & Branch DW 1990 Antiphospholipid antibodies and recurrent pregnancy loss: correlation between the activated partial thromboplastin time and antibodies against phosphatidylserine and cardiolipin. American Journal of Obstetrics and Gynecology 163 575-584. (doi:10.1006/clin.1993.1025)
98. Ruffatti A, Tonello M, Visentin MS, Bontadi A, Hoxha A, De Carolis S, Botta A, Salvi S, Nuzzo M, Rovere-Querini P et al. 2011 Risk factors for pregnancy failure in patients with anti-phospholipid syndrome treated with conventional therapies: a multicentre, case-control study. Rheumatology 50 1684-1689. (doi:10.1093/rheumatology/ker139)
99. Salafia C & Cowchock F 1997 Placental pathology and antiphospholipid antibodies: a descriptive study. American Journal of Perinatology 14 435. (doi:10.1016/j.placenta.2015.11.010)
100. Salmon JE, Heuser C, Triebwasser M, Liszewski MK, Kavanagh D, Roumenina L, Branch DW, Goodship T, Fremeaux-Bacchi V & Atkinson JP 2011 Mutations in complement regulatory proteins predispose to preeclampsia: a genetic analysis of the PROMISSE cohort. PLoS Medicine 8 e1001013. (doi:10.1371/journal.pmed.1001013)
101. Schwartz N, Shoenfeld Y, Barzilai O, Cervera R, Font J, Blank M, Yacobi S, Patlas N, Cohen A, Mevorach D et al. 2007 Reduced placental growth and hCG secretion in vitro induced by antiphospholipid antibodies but not by anti-Ro or anti-La: studies on sera from women with SLE/PAPS. Lupus 16 110-120. (doi:10.1177/0961203306075741)
102. Shamonki JM, Salmon JE, Hyjek E & Baergen RN 2007 Excessive complement activation is associated with placental injury in patients with antiphospholipid antibodies. American Journal of Obstetrics and Gynecology 196 167 e161-e165. (doi:10.1016/j.ajog.2006.10.879)
103. Silver RM, Parker CB, Reddy UM, Goldenberg R, Coustan D, Dudley DJ, Saade GR, Stoll B, Koch MA, Conway D et al. 2013 Antiphospholipid antibodies in stillbirth. Obstetrics and Gynecology 122 641-657. (doi:10.1097/AOG.0b013e3182a1060e)
104. Sorice M, Longo A, Capozzi A, Garofalo T, Misasi R, Alessandri C, Conti F, Buttari B, Rigano R, Ortona E et al. 2007 Anti-β2-glycoprotein I antibodies induce monocyte release of tumor necrosis factor a and tissue factor by signal transduction pathways involving lipid rafts. Arthritis & Rheumatology 56 2687-2697. (doi:10.1002/(ISSN)1529-0131)
105. Suzuki T, Takabayashi K, Ichikawa K, Itou I, Ishiguro N, Yoshiki T & Koike T 1996 Effects of monoclonal anticardiolipin antibody on pregnant mice. Journal of Rheumatology 23 83-86.
106. Tong M, Viall CA & Chamley LW 2015 Antiphospholipid antibodies and the placenta: a systematic review of their in vitro effects and modulation by treatment. Human Reproduction Update 21 97-118. (doi:10.1093/humupd/dmv006)
107. Ueki H, Mizushina T, Laoharatchatathanin T, Terashima R, Nishimura Y, Rieanrakwong D, Yonezawa T, Kurusu S, Hasegawa Y, Brachvogel B et al. 2012 Loss of maternal annexin A5 increases the likelihood of placental platelet thrombosis and fetal loss. Scientific Reports 2 827.
108. Ulrich V, Gelber SE, Vukelic M, Sacharidou A, Herz J, Urbanus RT, de Groot PG, Natale DR, Harihara A, Redecha P et al. 2016 ApoE Receptor 2 mediates trophoblast dysfunction and pregnancy complications induced by antiphospholipid antibodies in mice. Arthritis & Rheumatology 68 730-739. (doi:10.1002/art.39453)
109. Viall CA & Chamley LW 2015 Histopathology in the placentae of women with antiphospholipid antibodies: a systematic review of the literature. Autoimmunity Reviews 14 446-471. (doi:10.1016/j.placenta.2015.10.006)
110. Viall CA, Chen Q, Liu B, Hickey A, Snowise S, Salmon JE, Stone PR & Chamley LW 2013 Antiphospholipid antibodies internalised by human syncytiotrophoblast cause aberrant cell death and the release of necrotic trophoblast debris. Journal of Autoimmunity 47 45-57. (doi:10.1016/j.jaut.2013.08.005)
111. White CA, Johansson M, Roberts CT, Ramsay AJ & Robertson SA 2004 Effect of interleukin-10 null mutation on maternal immune response and reproductive outcome in mice. Biology of Reproduction 70 123-131.
112. Wu R, Svenungsson E, Gunnarsson I, Haegerstrand-Gillis C, Andersson B, Lundberg I, Elinder LS & Frostegard J 1999 Antibodies to adult human endothelial cells cross-react with oxidized low-density lipoprotein and β2-glycoprotein I (β2-GPI) in systemic lupus erythematosus. Clinical and Experimental Immunology 115 561-566. (doi:10.1046/j.1365-2249.1999.00830.x)
113. Yacobi S, Ornoy A, Blumenfeld Z & Miller RK 2002 Effect of sera from women with systemic lupus erythematosus or antiphospholipid syndrome and recurrent abortions on human placental explants in culture. Teratology 66 300-308. (doi:10.1191/0961203303lu405oa)
114. Yasuda M, Takakuwa K, Tokunaga A & Tanaka K 1995 Prospective studies of the association between anticardiolipin antibody and outcome of pregnancy. Obstetrics and Gynecology 86 555-559. (doi:10.1016/S0029-7844(95)80015-8)
115. Ziakas PD, Pavlou M & Voulgarelis M 2010 Heparin treatment in antiphospholipid syndrome with recurrent pregnancy loss a systematic review and meta-analysis. Obstetrics and Gynecology 115 1256-1262. (doi:10.1016/j.ejogrb.2015.06.005)